Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
hemic and lymphatic diseases | D006425 |
Brand Name | Status | Last Update |
---|---|---|
fulphila | Biologic Licensing Application | 2023-12-05 |
fylnetra | Biologic Licensing Application | 2022-05-31 |
neulasta | Biologic Licensing Application | 2024-10-31 |
nyvepria | Biologic Licensing Application | 2023-06-29 |
stimufend | Biologic Licensing Application | 2023-10-24 |
udenyca | Biologic Licensing Application | 2024-08-20 |
ziextenzo | Biologic Licensing Application | 2022-12-14 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
neutropenia | — | D009503 | D70 |
Expiration | Code | ||
---|---|---|---|
pegfilgrastim, Neulasta, Amgen Inc. | |||
2122-11-13 | Orphan excl. | ||
pegfilgrastim, Neulasta Onpro, Amgen Inc. | |||
2122-11-13 | Orphan excl. |
Code | Description |
---|---|
J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
Q5108 | Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg |
Q5111 | Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg |
Q5120 | Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg |
Q5122 | Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 8 | 1 | 1 | 4 | 14 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 6 | — | 1 | 3 | 10 |
Neutropenia | D009503 | — | D70 | — | 2 | 2 | 2 | 1 | 7 |
Lung neoplasms | D008175 | — | C34.90 | — | 2 | — | 2 | 2 | 6 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 3 | — | 1 | 1 | 5 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 2 | — | 1 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | — | 2 | 1 | — | — | 3 |
Fever | D005334 | — | R50.9 | — | 1 | 1 | — | 1 | 3 |
Leukemia | D007938 | — | C95 | — | 1 | 1 | — | — | 2 |
Colorectal neoplasms | D015179 | — | — | — | 1 | 1 | — | — | 2 |
Colonic neoplasms | D003110 | — | C18 | — | 1 | 1 | — | — | 2 |
Rectal neoplasms | D012004 | — | — | — | 1 | 1 | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | 1 | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 2 | 8 | — | — | 1 | 10 |
Sarcoma | D012509 | — | — | — | 2 | — | — | 1 | 3 |
B-cell lymphoma | D016393 | — | — | 1 | 3 | — | — | — | 3 |
Multiple myeloma | D009101 | — | C90.0 | — | 3 | — | — | — | 3 |
Plasma cell neoplasms | D054219 | — | — | — | 3 | — | — | — | 3 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | 2 | — | — | — | 2 |
Aggression | D000374 | EFO_0003015 | — | 2 | 1 | — | — | — | 2 |
Male breast neoplasms | D018567 | — | — | — | 1 | — | — | — | 1 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 1 | 1 | — | — | — | 1 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chemotherapy-induced febrile neutropenia | D064146 | — | — | — | — | — | — | 1 | 1 |
Febrile neutropenia | D064147 | — | — | — | — | — | — | 1 | 1 |
Hyperthermia | D000084462 | — | — | — | — | — | — | 1 | 1 |
Adenocarcinoma | D000230 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Pegfilgrastim |
INN | pegfilgrastim |
Description | Granulocyte colony-stimulating factor precursor (G-CSF) (Pluripoietin) |
Classification | Protein |
Drug class | PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer; colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201568 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00019 |
UNII ID | 3A58010674 (ChemIDplus, GSRS) |